Optima Pharma

Optima Pharma, headquartered in DE and operating within the chemical and fertilizer minerals, salt, and other mining and quarrying products sector, has reported Scope 1 and 2 emissions data.

For the year 2024, Optima Pharma's Scope 1 emissions were approximately 1,554,000 kg CO2e, and its Scope 2 emissions were approximately 1,422,000 kg CO2e. In 2023, Scope 1 emissions totalled around 1,482,000 kg CO2e, with Scope 2 emissions at approximately 1,164,000 kg CO2e. The company reported Scope 1 emissions of about 1,451,000 kg CO2e and Scope 2 emissions of approximately 1,326,000 kg CO2e for 2022.

Optima Pharma has stated a commitment to reducing its Scope 1 and 2 carbon footprint from its own operations by at least 50% by 2030, using 2021 as a baseline. Furthermore, the company aims to achieve net zero emissions by 2050. These targets are cascaded from its parent organisation, OPTIMA packaging group GmbH. Optima Pharma has also committed to compensating 100% of non-avoidable emissions over the coming years, with a long-term timeframe extending to 2050. For near-term targets, Optima Pharma aims for an additional 25% reduction in emissions by 2030 through increased energy and resource efficiency and expanded sustainable mobility initiatives. The company has been sourcing green electricity since 2009 and has already reduced its operational carbon footprint by 40% through various measures.

While Scope 3 emissions data is not fully disclosed, the company acknowledges missing data points in this category, specifically regarding purchased goods and services. In 2020, Optima Pharma reported total emissions of approximately 372,000 kg CO2e, comprising Scope 1 (around 11,160 kg CO2e), Scope 2 (about 11,160 kg CO2e), and Scope 3 (approximately 349,680 kg CO2e). In 2014, total emissions were approximately 383,000 kg CO2e, with Scope 1 at about 22,980 kg CO2e, Scope 2 at approximately 15,320 kg CO2e, and Scope 3 at around 344,700 kg CO2e.